Parkinson Disease, Late-onset; Pd
Description
Parkinson disease was first described by James Parkinson in 1817. It is the second most common neurodegenerative disorder after Alzheimer disease (AD ), affecting approximately 1% of the population over age 50 (Polymeropoulos et al., 1996).
Genes related to Parkinson Disease, Late-onset; Pd
- ADH1C
- MAPT
- GBA
- GLUD2
- TBP
- ATXN2
Clinical Features
Top most frequent phenotypes and symptoms related to Parkinson Disease, Late-onset; Pd
- Ataxia
- Cognitive impairment
- Dysarthria
- Tremor
- Dysphagia
- Dystonia
- Depressivity
- Constipation
- Dementia
- Rigidity
And another 22 symptoms. If you need more information about this disease we can help you.
Incidence and onset information
— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)— No data available about the known clinical features onset.
Alternative names
Parkinson Disease, Late-onset; Pd Is also known as park.
Researches and researchers
Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.Parkinson Disease, Late-onset; Pd Recommended genes panels
Panel Name, Specifity and genes Tested/covered |
---|
Parkinson disease (NGS panel for 33 genes).
By CGC Genetics (Portugal).
SLC6A3, SNCA, SNCAIP, SNCB, SYNJ1, TAF1, TH, GIGYF2, UCHL1, VPS35, FBXO7, HTRA2, PINK1, DNAJC6, PARK7, ATP6AP2, LRRK2, CSF1R, ADH1C, DCTN1 , (...)
View the complete list with 12 more genes
Specificity
10 %
Genes
50 % |
ADH1C.
By Fulgent Genetics Fulgent Genetics (United States).
ADH1C
Specificity
100 %
Genes
17 % |
MAPT DNA Sequencing Test.
By Athena Diagnostics Inc (United States).
MAPT
Specificity
100 %
Genes
17 % |
Frontotemporal Dementia (FTD) Evaluation.
By Athena Diagnostics Inc (United States).
C9orf72, GRN, MAPT
Specificity
34 %
Genes
17 % |
Frontotemporal Dementia (FTDP) - MAPT Gene, Exon 10 Only.
By Center for Genetics at Saint Francis Saint Francis Hospital (United States).
MAPT
Specificity
100 %
Genes
17 % |
Frontotemporal Dementia w/ Parkinsonism (FTDP) - MAPT Gene.
By Center for Genetics at Saint Francis Saint Francis Hospital (United States).
MAPT
Specificity
100 %
Genes
17 % |
Dementia.
By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University (United States).
SORL1, TARDBP, VCP, FIG4, OPTN, TREM2, CSF1R, CHMP2B, DCTN1, C9orf72, FUS, ALS2, SETX, GRN, ANG, APOE, APP, MAPT, PRNP, PSEN1 , (...)
View the complete list with 1 more genes
Specificity
5 %
Genes
17 % |
Movement Disorders Panel.
By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University (United States).
SCP2, SGCE, SLC20A2, SLC2A1, SLC6A3, SNCA, SPR, SQSTM1, SUCLA2, SUOX, TAF1, TH, TIMM8A, TREX1, MCOLN1, VPS35, FBXO7, CACNA1A, NPC2, PINK1 , (...)
View the complete list with 72 more genes
Specificity
3 %
Genes
34 % |
You can get up to 249 more panels with our dedicated tool
Learn moreSources and references
You can check the following sources for additional information.
OMIM Rare Disease Search EngineIf you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2